Information about sponsored clinical trials and result information are provided for informational purposes only and are not intended to promote any product or use. Clinical study results are intended to report the results of the study that were known at the time of the study's completion. The results therefore do not provide a comprehensive and current review of the safety and efficacy of any drug based upon all information available. Physicians and patients should refer to the current approved product labeling for information on approved indications in their country.
This information is not intended to replace the advice of a health care professional. Only a physician can determine if a specific medicine is the correct or best treatment option for a particular patient. If you have questions, please consult a health care professional.

A - B - C - D - E - F - G - H I - J - K - L - M N - O - P - Q - R - S T - U - V - W - X - Y - Z

Clinical study results Sanofi pharma, including Sanofi Genzyme – Letter R

GENERIC NAME

TRADE NAME

CONDITION

STUDY CODE

STUDY NAME

ACCESS TO STUDY / PROTOCOL

ACCESS TO RESULTS

RABBIT ANTI-THYMOCYTE GLOBULIN

Thymoglobulin

Myelodysplastic Syndrome

ThymoHEM01206

RISE

NCT00542828

RABBIT ANTI-THYMOCYTE GLOBULIN

Thymoglobulin

End-stage Renal Disease

THYMOL07282

START-DCD

NCT03099122

RAMIPRIL

Triatec

Heart diseases

HOE498_3501

FOCUS

NCT00268619

RAMIPRIL

Triatec

Atherosclerosis

HOE498_4099

HOPE

NCT01053910

RAMIPRIL

Triatec

Glomerulonephritis

HOE498_6015

NA

NCT00437463

RAMIPRIL

Triatec

Hypertension

HOE498_3E03

PHARAO

NCT00325806

RAMIPRIL

Triatec

Coronary Artery Disease

RAMIP_L_03123

HOPETips

NCT03099213

RAMPIRIL + FELODIPINE

Triapin

Hypertension

RAMFE_L_03420

NA

NCT00841880

RAMPIRIL + FELODIPINE

Triapin

Hypertension

RAMIP_L_01961

RAFE HELP

NCT00507845

RASBURICASE

Elitek, Fasturtec

Hyperuricemia

ACT5080

NA

NCT00290992

RASBURICASE

Elitek, Fasturtec

Hyperuricemia

ARD5290

NA

NCT00631579

RASBURICASE

Elitek, Fasturtec

Tumor lysis syndrome

EFC4978

NA

NCT00230178

RASBURICASE

Elitek, Fasturtec

Cancer, Hyperuricemia

EFC4978

NA

NCT00230178

RASBURICASE

Elitek, Fasturtec

Hyperuricemia

EFC4983

GRAAL2

NCT00664144

RASBURICASE

Elitek, Fasturtec

Hyperuricemia

EFC5339

NA

NCT00230217

RASBURICASE

Elitek, Fasturtec

Tumor lysis syndrome

L_8637

NA

NCT00651911

RASBURICASE

Elitek, Fasturtec

Hematologic neoplasms

L_8720

NA

NCT00563771

RASBURICASE

Elitek, Fasturtec

Hyperuricemia

L_9436

NA

NCT00302653

RASBURICASE

Elitek, Fasturtec

Hyperuricemia

RASBU_L_00351

NA

NCT00607152

RASBURICASE

Elitek, Fasturtec

Hyperuricemia

RASBUL09107

RAISE

2021-003176-14

RHO-KINASE INHIBITOR

Not marketed

Erectile Dysfunction

ACT10775

RHOKET

EudraCT: 2009-009936-56

RHO-KINASE INHIBITOR

Not marketed

Microvascular Coronary Artery Disease

ACT14656

NA

NCT03236311

RHO-KINASE INHIBITOR

Not marketed

Chronic Kidney Disease

TDR12446

NA

NCT01485900

RIFAPENTINE

Priftin

Tuberculosis

INT12291

NA

NCT01690403

RILUZOLE

Rilutek

Amyotrophic Lateral Sclerosis

RIL_CA1_401

CARE

NCT00542412

RILUZOLE

Rilutek

Amyotrophic Lateral Sclerosis

RIL_DE1_201

NA

NCT00277602

RILZABRUTINIB

Not marketed

Pemphigus

EFC17092

NA

NCT03762265

RIFERMINOGENE PECAPLASMID

Not marketed

Critical limb ischemia

EFC6145

TAMARIS

NCT00566657

RIMONABANT

Acomplia

Obesity

ACT3801

NA

NCT00481975

RIMONABANT

Acomplia

Obesity

DRI5747

NA

NCT00459004

RIMONABANT

Acomplia

Obesity

EFC4733

RIO-EUROPE

NCT00386061

RIMONABANT

Acomplia

Obesity

EFC4735

RIO-LIPIDS

NCT00029835

RIMONABANT

Acomplia

Obesity

EFC4736

RIO-DIABETES

NCT00029848

RIMONABANT

Acomplia

Obesity

EFC4743

RIO-NORTH AMERICA

NCT00029861

RIMONABANT

Acomplia

Smoking Cessation

EFC4796

STRATUS-WW

NCT00459173

RIMONABANT

Acomplia

Obesity

EFC4798

CIRRUS

NCT00458718

RIMONABANT

Acomplia

Diabetes, Type 2

EFC5593

ARPEGGIO

EudraCT: 2005-001613-17

RIMONABANT

Acomplia

Obesity Dyslipidemia

EFC5823

ADAGIO

EudraCT: 2005-000807-33

RIMONABANT

Acomplia

Obesity

EFC5827

STRADIVARIUS

NCT00124332

RIMONABANT

Acomplia

Obesity

EFC6001

RIO-ASIA

NCT00325546

RIMONABANT

Acomplia

Obesity

RIMON_R_00961

PRADO

NCT00405808

RIPK1 INHIBITOR

Not marketed

Amyotrophic Lateral Sclerosis

TDR16536

NA

NCT03757351

RISEDRONATE SODIUM

Actonel

Osteoporosis, Postmenopausal

EFC6063 (HMR4003B/4003)

NA

NCT00358176

RISEDRONATE SODIUM

Actonel

Osteoporosis, Postmenopausal

EFC6064

NA

NCT00353080

RISEDRONATE SODIUM

Actonel

Osteoporosis

HMR4003B_3507

OSMAUSE

EudraCT: 2005-005598-30

RISEDRONATE SODIUM

Actonel

Osteoporosis

HMR4003B_4001

IMPACT

NCT00268632

RISEDRONATE SODIUM

Actonel

Osteoporosis, Postmenopausal

HMR4003F/4001

NA

NCT00402441

RISEDRONATE SODIUM

Actonel

Osteoporosis, Postmenopausal

RISED_L_01930

SOLID

NCT00460733

RISEDRONATE SODIUM

Actonel

Bone Diseases

HMR4003B_2501

NA

NCT00351091

RISEDRONATE SODIUM

Actonel

Bone Diseases

HMR4003B_4027

ACTIVATE

NCT00616694

RISEDRONATE SODIUM

Actonel

Bone Diseases

HMR4003B_4031

POWER

NCT00549068

RISEDRONATE SODIUM

Actonel

Bone Diseases

HMR4003B_4033

NA

NCT00790101

RISEDRONATE SODIUM

Actonel

Bone Diseases

HMR4003B_4034

OPTAMISE

EudraCT: 2004-002317-37

RISEDRONATE SODIUM

Actonel

Bone Diseases

HMR4003B_4035

NA

NCT00549965

RISEDRONATE SODIUM

Actonel

Bone Diseases

HMR4003B_4036

NA

NCT00453492

RISEDRONATE SODIUM

Actonel

Bone Diseases

RISED_L_01054

NA

NCT00632216

RISEDRONATE SODIUM

Actonel

Bone Diseases

RISED_L_01686

ROSPA

NCT00544180

ROMILKIMAB

Not marketed

Idiopathic Pulmonary Fibrosis

DRI11772

ESTAIR

EudraCT: 2014-003933-24

ROMILKIMAB

Not marketed

Systemic Sclerosis

ACT14604

 

EudraCT: 2016-001028-80

ROMILKIMAB

Not marketed

Idiopathic Pulmonary Fibrosis

TDR11326

NA

NCT01529853


References:
*These study results were previously posted on GenzymeClinicalResearch.com
**This link replaces the same summary that was previously posted